# Primary Motor Cortex of the Parkinsonian Monkey: Differential Effects on the Spontaneous Activity of Pyramidal Tract-Type Neurons

**Citation**: Pasquereau B, Turner RS (2011) Primary motor cortex of the parkinsonian monkey: differential effects on the spontaneous activity of pyramidal tract-type neurons. *Cerebral Cortex* 21:1362-1378.

## Overview

This study examined the differential effects of MPTP-induced parkinsonism on the spontaneous (resting state) activity of pyramidal tract neurons (PTNs) and corticostriatal neurons (CSNs) in primary motor cortex (M1). The research demonstrated that parkinsonian pathology selectively affects PTNs while largely sparing CSNs, revealing a cell-type specific vulnerability pattern with important implications for understanding cortical contributions to Parkinson's disease motor symptoms.

## Introduction and Context

The basal ganglia model of Parkinson's disease predicts that dopamine depletion leads to excessive inhibition of thalamocortical projections, which should result in reduced cortical activity. However, direct evidence for cortical hypoactivity has been inconsistent. This study addressed this controversy by:

1. Recording from identified neuron types (PTNs vs CSNs) rather than unidentified cortical neurons
2. Examining spontaneous activity during rest, independent of motor task demands
3. Analyzing firing pattern characteristics (burstiness, rhythmicity) in addition to mean firing rates

### Theoretical Framework

The basal ganglia-thalamocortical circuit model predicts:
- Dopamine depletion increases striatal inhibition of GPe (external globus pallidus)
- Reduced GPe activity disinhibits STN (subthalamic nucleus)
- Increased STN drive to GPi (internal globus pallidus)
- Excessive GPi inhibition of thalamus
- Reduced thalamocortical excitation of M1

This cascade should produce cortical hypoactivity, but the cell-type specific effects had not been examined.

## Animals and MPTP Treatment

### Subjects
- Two female rhesus macaques (*Macaca mulatta*)
- **Monkey V**: 4.8 kg body weight
- **Monkey L**: 6.0 kg body weight
- Same subjects used across all three papers in the series

### MPTP Administration Protocol
- **Method**: Unilateral intracarotid injection
- **Dose**: 0.5 mg/kg MPTP-HCl dissolved in saline
- **Injection Site**: Left internal carotid artery
- **Effect**: Selective dopaminergic denervation of right hemisphere
- **Symptom Profile**: Moderate, stable hemiparkinsonian symptoms on left body side

### Timeline
- Pre-MPTP recordings: Extended baseline period
- MPTP injection: Single administration
- Post-MPTP recordings: Began after symptoms stabilized (approximately 1-2 weeks post-injection)
- Recording period: Continued for several months post-MPTP

## Neuron Types and Identification

### Pyramidal Tract Neurons (PTNs)

**Definition**: Large layer 5b pyramidal neurons projecting to the spinal cord via the corticospinal (pyramidal) tract.

**Antidromic Identification**:
- Stimulating electrodes placed in the cerebral peduncle
- Stimulation parameters: 0.2 ms biphasic pulses, 100-400 microAmps
- Antidromic latencies: 0.6-2.5 ms
- Fast conduction velocities indicate large-diameter axons

**Physiological Characteristics**:
- Higher spontaneous firing rates than CSNs
- Broader action potential waveforms
- More irregular firing patterns

### Corticostriatal Neurons (CSNs)

**Definition**: Intratelencephalic-type layer 5 neurons projecting to the striatum (putamen), providing cortical input to basal ganglia circuits.

**Antidromic Identification**:
- Stimulating electrodes placed in posterolateral putamen
- Stimulation parameters: 0.2 ms biphasic pulses, 100-600 microAmps
- Antidromic latencies: 2.0-20 ms
- Slower conduction velocities indicate smaller axons

**Physiological Characteristics**:
- Lower spontaneous firing rates than PTNs
- Narrower action potential waveforms
- More regular firing patterns

### Antidromic Identification Criteria
All neurons met three standard criteria:
1. **Fixed latency**: Consistent response latency across stimulations
2. **High-frequency following**: Ability to follow stimulation at >200 Hz
3. **Collision test**: Spontaneous spikes occurring within the critical window blocked the antidromic response

## Data Collection

### Neuron Sample Sizes

| Condition | PTNs | CSNs | Total |
|-----------|------|------|-------|
| Pre-MPTP  | 72   | 55   | 127   |
| Post-MPTP | 51   | 43   | 94    |
| **Total** | **123** | **98** | **221** |

### Recording Conditions
- **State**: Quiet rest (awake, alert, but not engaged in task)
- **Duration**: Minimum 60 seconds of stable recording per neuron
- **Verification**: Absence of movement confirmed by EMG and behavioral monitoring
- **Electrode**: Glass-coated tungsten microelectrodes

## Analysis Methods

### Firing Rate Analysis
- Mean spontaneous firing rate (spikes/second)
- Coefficient of variation (CV) of interspike intervals
- Comparison of pre- vs post-MPTP distributions

### Burst Analysis
- **Burst definition**: Groups of spikes with interspike intervals <10 ms
- **Burst rate**: Number of bursts per second
- **Burst proportion**: Percentage of spikes occurring in bursts
- **Poisson Surprise method**: Statistical identification of bursts

### Oscillatory Activity Analysis
- **Power spectral analysis**: Fast Fourier Transform of spike trains
- **Beta-band power**: 14-32 Hz frequency range
- **Coherence analysis**: Synchronization between neurons
- **Beta rhythmicity index**: Quantification of oscillatory activity strength

### Statistical Methods
- Two-sample t-tests for group comparisons
- Kolmogorov-Smirnov tests for distribution comparisons
- Bootstrap confidence intervals
- Effect size calculations

## Key Findings

### Differential Effects on Firing Rates

#### Pyramidal Tract Neurons (PTNs)
- **27% reduction** in mean spontaneous firing rate after MPTP
- Pre-MPTP mean: ~15 spikes/second
- Post-MPTP mean: ~11 spikes/second
- Highly significant (p < 0.001)

#### Corticostriatal Neurons (CSNs)
- **No significant change** in spontaneous firing rate
- Pre-MPTP mean: ~8 spikes/second
- Post-MPTP mean: ~8 spikes/second
- Activity levels preserved

### Increased Burstiness in PTNs

Post-MPTP PTNs showed:
- **Increased burst rate**: More frequent bursts
- **Increased burst proportion**: Higher percentage of spikes in bursts
- **More irregular firing**: Increased coefficient of variation (CV) of ISIs
- **Shorter interspike intervals within bursts**

CSNs showed no significant changes in firing pattern characteristics.

### Enhanced Beta-Frequency Oscillatory Activity

#### PTN Beta Rhythmicity
- **Significant increase** in 14-32 Hz power spectral density
- Post-MPTP PTNs showed prominent beta peaks in autocorrelograms
- Increased beta coherence between simultaneously recorded PTNs
- Beta rhythmicity correlated with parkinsonian symptom severity

#### CSN Beta Activity
- No significant change in beta-band power
- Maintained normal, non-rhythmic firing patterns

### Summary Table of Effects

| Measure | PTN Change | CSN Change |
|---------|------------|------------|
| Firing rate | -27% | No change |
| Burst rate | Increased | No change |
| Burst proportion | Increased | No change |
| CV of ISI | Increased | No change |
| Beta power | Increased | No change |
| Regularity | Decreased | Maintained |

## Interpretation

### Selective PTN Vulnerability

The differential effects on PTNs vs CSNs suggest:

1. **Different Input Sources**: PTNs may receive stronger thalamocortical input (affected by basal ganglia dysfunction) while CSNs may have more diverse input sources
2. **Circuit Position**: PTNs represent the output layer of M1; disrupted basal ganglia-thalamocortical activity preferentially affects this output pathway
3. **Intrinsic Properties**: PTNs and CSNs may have different intrinsic membrane properties affecting their susceptibility to altered inputs

### Origins of Abnormal Firing Patterns

The increased burstiness and beta rhythmicity in PTNs may arise from:

1. **Reduced Tonic Drive**: Loss of steady thalamocortical excitation may unmask intrinsic bursting tendencies
2. **Pathological Oscillations**: Abnormal beta oscillations in basal ganglia-thalamocortical circuits are transmitted to cortex
3. **Altered Inhibition**: Changes in local interneuron activity may contribute to firing pattern abnormalities

### Functional Implications

| Abnormality | Potential Motor Consequence |
|-------------|----------------------------|
| PTN hypoactivity | Reduced motor commands to spinal cord |
| Increased burstiness | Disrupted temporal coding of movements |
| Beta rhythmicity | Interference with movement initiation |
| Preserved CSN activity | Maintained feedback to basal ganglia |

## Clinical Relevance

### Neural Basis of Parkinsonian Symptoms

1. **Bradykinesia/Akinesia**: PTN hypoactivity reduces the drive for movement initiation
2. **Movement Initiation Deficits**: Abnormal beta oscillations may "hold" the motor system in a static state
3. **Preserved Cognitive Function**: Intact CSN activity may explain why corticostriatal circuits supporting cognitive functions are relatively spared

### Relationship to Other Findings

- Consistent with PET studies showing reduced M1 metabolism in PD
- Explains why DBS (which may disrupt pathological oscillations) improves motor function
- Provides circuit-level mechanism for thalamocortical contribution to parkinsonism

### Therapeutic Implications

- Treatments targeting PTN hypoactivity specifically may be beneficial
- Beta oscillation suppression (e.g., via DBS) addresses a pathological correlate
- Differential vulnerability suggests potential for cell-type specific interventions

## Significance

This research reveals that parkinsonian pathology affects cortical neurons in a cell-type specific manner:

1. **PTNs are selectively vulnerable**: Both firing rate and firing pattern abnormalities
2. **CSNs are relatively spared**: Maintained activity levels and patterns
3. **Beta rhythmicity is pathological**: Linked to abnormal basal ganglia-thalamocortical dynamics
4. **Cortical dysfunction is primary**: Not secondary to movement deficits (recorded at rest)

These findings demonstrate that cortical contributions to Parkinson's disease are substantial and cell-type specific, with the corticospinal output pathway (PTNs) showing particular vulnerability while corticostriatal feedback (CSNs) is preserved. This differential effect has important implications for understanding symptom mechanisms and developing targeted therapies.
